BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20101237)

  • 1. ARF-induced downregulation of Mip130/LIN-9 protein levels mediates a positive feedback that leads to increased expression of p16Ink4a and p19Arf.
    Song J; Sandoval R; Pilkinton MA; Tian X; Raychaudhuri P; Colamonici OR
    Oncogene; 2010 Apr; 29(13):1976-86. PubMed ID: 20101237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
    Sebastian T; Johnson PF
    Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex.
    Sandoval R; Pilkinton M; Colamonici OR
    Exp Cell Res; 2009 Oct; 315(17):2914-20. PubMed ID: 19619530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
    Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
    Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway.
    Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T
    Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A; Iaquinta PJ; Verona R; Lees JA
    Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
    Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
    Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.
    Gonzalez S; Klatt P; Delgado S; Conde E; Lopez-Rios F; Sanchez-Cespedes M; Mendez J; Antequera F; Serrano M
    Nature; 2006 Mar; 440(7084):702-6. PubMed ID: 16572177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HuR maintains a replicative life span by repressing the ARF tumor suppressor.
    Kawagishi H; Hashimoto M; Nakamura H; Tsugawa T; Watanabe A; Kontoyiannis DL; Sugimoto M
    Mol Cell Biol; 2013 May; 33(10):1886-900. PubMed ID: 23508105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.
    Baker DJ; Perez-Terzic C; Jin F; Pitel KS; Niederländer NJ; Jeganathan K; Yamada S; Reyes S; Rowe L; Hiddinga HJ; Eberhardt NL; Terzic A; van Deursen JM
    Nat Cell Biol; 2008 Jul; 10(7):825-36. PubMed ID: 18516091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
    Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
    PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.
    Sachs Z; Sharpless NE; DePinho RA; Rosenberg N
    J Virol; 2004 Apr; 78(7):3304-11. PubMed ID: 15016851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
    Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
    Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
    Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
    EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
    Randle DH; Zindy F; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.
    Radfar A; Unnikrishnan I; Lee HW; DePinho RA; Rosenberg N
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13194-9. PubMed ID: 9789064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.